Abstract
Joint programming (JP) has been a significant tool for planning and implementing research and development actions in Europe in this millennium. The European Union, along with its Member States and partners from associated and third countries, has endeavored to adopt a more coordinated approach to financing, planning, and implementing research and innovation activities through joint actions.
The Joint Program Initiative on Antimicrobial Resistance, JPIAMR, is an international collaborative platform involving 29 countries and the European Commission in the fight against antimicrobial resistance (AMR). JPIAMR coordinates national research funding and supports collaborative efforts to address AMR knowledge gaps from the One Health perspective. The JPIAMR program identifies key areas that require attention and provides guidance to countries, aiming to harmonize national and international AMR research programs to combat antimicrobial resistance globally. Aligned with the six strategic directions of the general research and innovation agenda of JPIAMR, the partnership engages in a wide range of activities with a One Health approach, seeking and supporting solutions to reduce the transmission of antimicrobial-resistant bacteria.
|Views: 63| |pdf Downloads: 34|
This work is licensed under a Creative Commons Attribution 4.0 International License.